Allied Market Research published a report, titled, “DTP Vaccine Market by Product Type (DTaP vaccine (Diphtheria-Tetanus-acellular Pertussis vaccine), TD (Tetanus and Diphtheria) vaccine, and Tdap (Tetanus-Diphtheria-Acellular Pertussis) vaccine, by Age Group (Adult and Pediatric), and by End User (Hospitals, Clinics, and Vaccination Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027.” According to the report, the global diphtheria, pertussis, and tetanus vaccine (DTP) market garnered $4.75 billion in 2019, and is estimated to reach $7.05 billion by 2027, registering a CAGR of 5.1% from 2020 to 2027.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/3810
Drivers, restraints, and opportunities-
Rise in initiatives by pharmaceutical companies to enhance R&D for vaccines and growth in awareness among people about the advantages of DTP vaccines drive the growth of the global diphtheria, pertussis, and tetanus vaccine (DTP) market. However, high production cost of vaccine and inadequate access to vaccines in under developed countries hinder the market growth. On the other hand, innovative vaccine technologies are anticipated to offer new opportunities in the coming years.
Covid-19 Scenario-
- The coronavirus outbreak has not much affected the global diphtheria, pertussis, and tetanus vaccine (DTP) market. In addition, due to the DTP vaccine recommended for the treatments on respiratory tract and throat infection, the market has witnessed an increased.
- Moreover, due to the rise in awareness regarding common symptoms of coronavirus, the market has observed increased use of DTP vaccines.
The DtaP segment to maintain its lead status-
Based on product type, the DTaP segment accounted for more than three-fifths of the global diphtheria, pertussis, and tetanus vaccine (DTP) market in 2019, and is expected to maintain its lead status in terms of revenue throughout the forecast period. This is due to increase in use of DTaP vaccine in the treatment of infectious disease. However, the Tdap is estimated to portray the highest CAGR of 5.5% from 2020 to 2027.
The pediatric segment to maintain its leadership position-
Based on age group, the pediatric segment contributed to the highest market share with around three-fourths of the global diphtheria, pertussis, and tetanus vaccine (DTP) market in 2019, and is estimated to maintain its leadership position during the forecast period. This is attributed to growth in research and development (R&D) activities and increase in demand for DTP vaccine among infants. However, the adult segment is estimated to generate the fastest CAGR of 5.5% from 2020 to 2027. This is attributed to rise in incidences of infectious diseases among adults.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3810
North America is anticipated to dominate the market by 2027
Based on region, North America accounted for the highest share based on revenue, holding for nearly two-fifths of the global diphtheria, pertussis, and tetanus vaccine (DTP) market in 2019, and is projected to maintain its dominant position throughout the forecast period. This is attributed to the presence of maximum number of key players in this region. However, the Asia-Pacific is estimated to generate the fastest CAGR of 6.1% from 2020 to 2027. This is attributed to the established immunization structures and high health awareness among people in this region.
Leading market players
- AJ Vaccines
- Bionet-Asia
- GlaxoSmithKline plc (GSK)
- Johnson & Johnson
- Massbiologics
- Meiji Holdings Co.
- Ltd. (KM biologics co., Ltd.)
- Merck & Co., Inc.
- Panacea Biotec Ltd.
- Sanofi
- Serum Institute of India Pvt. Ltd.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
